Abstract
Interferon-γ (IFN-γ), a primary cytokine for the development of inflammatory responses, plays an essential role in host defense but has the potential to induce pathologic changes. Initially, IFN-γ was believed to be produced by limited sets of cells, such as T-cells and natural killer (NK) cells. T-cells need to develop into T-helper type 1 (Thl) cells to gain the capacity to produce IFN-γ in response to antigen (Ag) (1). In contrast, NK cells can produce IFN-γ in response to IL-12 without such differentiation (2). Discovery of IL-18 significantly changed this scenario for explaining IFN-γ production (3–10). First, upon stimulation with IL-18 and IL-12 without T-cell receptor (TCR) engagement, freshly isolated Th cells and Thl cells can produce higher levels of IFN-γ than Ag-stimulated Thl cells. IL-18 only moderately upregulates IFN-γ production by Thl cells stimulated with TCR engagement. Moreover, IL-18, unlike IL-12, has no activity to induce Thl cell development in naive Th cells per se (11). These findings suggest a minor role for IL-18 in adaptive immunity, but the importance of IL-18 in innate immunity. Second, IL-18 synergizes with IL-12 for IFN-γ production by a wide range of cell types, including NK cells, and B-cells, macrophages, dendritic cells, and smooth muscle cells (9,12–15). This TCR engagement-independent IFN-γ induction is a unique property of IL-18/IL-12 biology (Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Murphy, K. M., Ouyang, W., Farrar, D. J., et al. (2000) Signaling and transcription in T helper development. Annu. Rev. Immunol. 18, 451 - 494.
Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific and adaptive immunity. Annu. Rev. Immunol. 13, 251 - 276.
Okamura, H., Tsutsui, H., Komatsu, T., et al. (1995) Cloning of a new cytokine that induces IFNy production by T cells. Nature 378, 88 - 91.
Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T., and Nakanishi, K. (1998) Interleukin18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70, 281 - 312.
Okamura, H., Kashiwamura, S., Tsutsui, H., Yoshimoto, T., and Nakanishi, K. (1998) Regulation of interferon-y production by IL-12 and IL-18. Curr. Opin. Immunol. 10, 259 - 264.
Fantuzzi, G. and Dinarello, C. A. (1999) Interleukin-18 and interleukin-1[3: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 19, 1 - 11.
Dinarello, C. A. (2000) Interleukin-18, a proinflammatory cytokine. Eur. Cytokine Netw. 11, 483-486.
Tsutsui, H., Matsui, K., Okamura, H., and Nakanishi, K. (2000) Pathophysiological roles of interIeukin-18 for inflammatory liver diseases. Immunol. Rev. 174, 192 - 209.
Nakanishi, K., Yoshimoto, T., Tsutsui, H., and Okamura, H. (2001) Interleukin-18 regulates both Thl and Th2 responses. Annu. Rev. Immunol. 19, 423 - 474.
Nakanishi, K., Yoshimoto, T., Tsutsui, H., and Okamura, H. (2001) Interleukin-18 is a unique cytokine that stimulates both Thl and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12, 53 - 72.
Robinson, D., Shibuya, K., Mui, A., et al. (1997) IGIF does not drive Thl development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF-KB. Immunity 7, 571 - 581.
Yoshimoto, T., Okamura, H., Tagawa, Y., Iwakura, Y., and Nakanishi, K. (1997) Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-y production from activated B cells. Proc. Natl. Acad. Sci. USA 94, 3948 - 3953.
Munder, M., Mallo, M., Eichmann, K., and Modolell, M. (1998) Murine macrophages secrete interferon y upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187, 2103 - 2108.
Fukao, T., Matsuda, S., and Koyasu, S. (2000) Synergistic effects of IL-4 and IL-18 on IL-12dependent IFN-y production by dendritic cells. J. Immunol. 164, 64 - 71.
Gerdes, N., Sukhova, G. K., Libby, P., Reynolds, R. S., Young, J. L., and Schönbeck, U. (2002) Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J. Exp. Med. 195, 245 - 257.
Oppmann, B., Lesley, R., Blom, B., et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715 - 725.
Parham, C., Chirica, M., Timans, J., et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rß1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699 - 5708.
Pflanz, S., Timans, J. C., Cheung, J., et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16, 779 - 790.
Yoshida, H., Hamano, S., Senaldi, G., et al. (2001) WSX-1 is required for the initiation of Thl responses and resistance to L. major infection. Immunity 15, 569 - 578.
Chen, Q., Ghilardi, N., Wang, H., et al. (2000) Development of Thl-type immune responses requires the type 1 cytokine receptor TCCR. Nature 07, 916 - 920.
Dinarello, C. A. (1999) Interleukin-18. Methods 19, 123 - 132.
Sims, J. E. (2002) IL-1 and IL-18 receptors, and their extended family. Curr. Opin. Immunol. 14, 117 - 122.
Bazan, J. F., Timans, J. C., and Kastelein, R. A. (1996) A newly defined interleukin-1? Nature 379, 591.
Gu, Y., Kuida, K., Tsutsui, H., et al. (1997) Activation of interferon-y inducing factor mediated by interleukin-113 converting enzyme. Science 275, 206 - 209.
Ghayur, T., Banerjee, S., Hugunin, M., et al. (1997) Caspase-1 processes IFN-y-inducing factor and regulates LPS-induced IFN-y production. Nature 386, 619 - 623.
Tsutsui, H., Kayagaki, N., Kuida, K., et al. (1999) Caspase-l-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11, 359 - 367.
Debets, R., Timans, J. C., Homey, B., et al. (2001) Two novel IL-1 family members, IL-18 and IL-le, function as an antagonist and agonist of NF-KB activation through the orphan IL-1 receptor-related protein 2. J. Immunol. 167, 1440 - 1446.
Stoll, S., Muller, G., Kurimoto, M., et al. (1997) Production of IL-18 (IFN-y-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159, 298 - 302.
Seki, E., Tsutsui, H., Nakano, H., et al. (2001) LPS-induced IL-18 secretion from murine Kupffer cells independently of MyD88 that is critically involved in induction of production of IL-12 and IL-1ßJ. Immunol. 166, 2651 - 2657.
Morelli, A. E., Zahorchak, A. F., Larregina, A. T., Colvin, B. L., Logar, A. J., and Takayama, T. (2001) Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 98, 1512 - 1523.
Akira, S., Takeda, K., and Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675 - 680.
Adachi, O., Kawai, T., Takeda, K., et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL- 18-mediated function. Immunity 9, 143 - 150.
Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S., and Suda, T. (1998) Caspase-l-independent IL-113 release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 4, 1287 - 1292.
Yoshimoto, T., Takeda, K., Tanaka, T., et al. (1998) IL-12 up-regulates IL-18 receptor expression on T cells, Thl cells, and B cells: synergism with IL-18 for IFN-y production. J. Immunol. 161, 3400 - 3407.
O'Neill, L. A. and Dinarello, C. A. (2000) The IL-1 receptor/toll-like receptor superfamily: critical receptors for inflammation and host defense. Immunol. Today 21, 206 - 209.
Suzuki, N., Suzuki, S., Duncan, G. S., et al. (2002) Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature 416, 750 - 754.
b. Suzuki, N., Chen, N.-J., Miller, D. G., et al. (2003) IRAK-4 is essential for interleukin-18-mediated natural killer and T helper cell type 1 response. J. Immunol. (in press).
Kanakaraj, P., Ngo, K., Wu, Y., et al. (1999) Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 189, 1129 - 1138.
Born, T. L., Thomassen, E., Bird, T. A., and Sims, J. E. (1998) Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273, 29445 - 29450.
Hyodo, Y., Matsui, K., Hayashi, N., et al. (1999) IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162, 1662 - 1668.
Nakahira, M., Tomura, M., Iwasaki, M., et al. (2001) An absolute requirement for STAT4 and a role for IFN-y as an amplifying factor in IL-12 induction for the functional IL-18 receptor complex. J. Immunol. 167, 1306 - 1312.
Freudenberg, M. A., Merlin, T., Kalis, C., Chvatchko, Y., Stübig, H., and Galanos, C. (2002) A murine, IL-12-independent pathway of IFN-y induction by gram-negative bacteria based on STAT4 activation by type 1 IFN and IL-18 signaling. J. Immunol. 169, 1665 - 1668.
Matikainen, S., Paananen, A., Miettinen, M., et al. (2001) IFN-a and IL-18 synergistically enhance IFN-y production in human NK cells: differential regulation of Stat4 activation and IFN-y gene expression by IFN-a and IL-12. Eur. J. Immunol. 31, 2236 - 2245.
Tominaga, K., Yoshimoto, T., Torigoe, K., et al. (2000) IL-12 synergizes with IL-18 or IL-113 for IFN-y production from human T cells. Int. Immunol. 12, 151 - 160.
Smeltz, R. B., Chen, J., Gu-Li, J., and Shevach, E. M. (2001) Regulation of interleukin (IL)-18 receptor a chain expression on CD4+ T cells during T helper (Th) 1/Th2 differentiation: critical downregulatory role of IL-4. J. Exp. Med. 194, 143 - 153.
Smeltz, R. B., Chen, J., Ehrhardt, R., and Shevach, E. M. (2002) Role of IFN-yin Thl differentiation: IFN-y regulates IL-18Ra expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor 132 expression. J. Immunol. 168, 6165 - 6172.
Kohno, K., Kataoka, J., Ohtsuki, T., et al. (1997) IFN-y-inducing factor (IGIF) is a costimulatory factor on the activation of Thl but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158, 1541 - 1550.
Xu, D., Chan, W. L., Leung, B. P., et al. (1998) Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 188, 1485 - 1492.
Ahn, H. J., Maruo, S., Tomura, M., et al. (1997) A mechanism underlying synergy between IL-12 and IFN-y-inducing factor in enhanced production of IFN-y. J. Immunol. 159, 2125 - 2131.
Nakahira, M., Ahn, H.-J., Park, W.-R., et al. (2002) Synergy of IL-12 and IL-18 for IFN-y gene expression: IL-12-induced STAT4 contributes to IFN-y promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J. Immunol. 168, 1146 - 1153.
Kaplan, M. H., Sun, Y. L., Hoey, T., and Grusby, M. J. (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174 - 177.
Barbulescu, K., Becker, C., Schlaak, J. F., Schmitt, E., Meyer zum Büschenfelde, K., and Neurath, M. F. (1998) IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-y promoter in primary CD4+ T lymphocytes. J. Immunol. 160, 3642 - 3647.
Shimoda, K., Tsutsui, H., Aoki, K., et al. (2002) Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice. Blood 99, 2094 - 2099.
Shimoda, K., Kato, K., Aoki, K., et al. (2000) Tyk2 plays a restricted role in IFN-a signaling, although it is required for IL-12-mediated T cell function. Immunity 13, 561 - 571.
Kalina, U., Kauschat, D., Koyama, N., et al. (2000) IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-y production by the stress kinase p38 and by the extracellular regulated kinases p44erk_I and p42erk-27 J Immunol. 165, 1307 - 1313.
Morel, J. C., Park, C. C., Zhu, K., Kumar, P., Roth, J. H., and Koch, A. E. (2002) Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast IL-18-induced vascular cell adhesion molecule-1 expression. J. Biol. Chem. 277, 34679 - 34691.
Nakanishi, K. (2001) Innate and acquired activation pathways in T cells. Nat. Immunol. 2, 140 - 142.
Yang, J., Zhu, H., Murphy, T. L., Ouyang, W., and Murphy, K. M. (2001) IL-18-stimulated GADD4513 required in cytokine-induced, but not TCR-induced, IFN-y production. Nat. Immunol. 2, 157 - 164.
Lu, B., Yu, H., Chow, C., et al. (2001) GADD45y mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector Thl cells. Immunity 14, 583 - 590.
Fornace, A. J. Jr., Jackman, J., Hollander, M. C., Hoffman-Liebermann, B., and Liebermann, D. A. (1992) Genotoxic-stress-response genes and growth-arrest genes. gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann. NY Acad. Sci. 663, 139 - 153.
Hollander, M. C., Sheikh, M. S., Bulavin, D. V., et al. (1999) Genomic instability in Gadd45adeficient mice. Nat. Genet. 23, 176 - 184.
Abdollahi, A., Lord, K. A., Hoffman-Liebermann, B., and Liebermann, D. A. (1991) Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene 6, 165 - 167.
Beadling, C., Johnson, K. W., and Smith, K. A. (1993) Isolation of interleukin 2-induced immediate-early genes. Proc. Natl. Acad. Sci. USA 90, 2719 - 2723.
Takekawa, M. and Saito, H. (1998) A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4/MAPKKK. Cell 95, 521 - 530.
Hoshino, K., Kashiwamura, S., Kuribayashi, K., et al. (1999) The absence of interleukin l receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 190, 1541 - 1547.
Chan, W. L., Pejnovic, N., Lee, C. A., and Al-Ali, N. A. (2001) Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes. J. Immunol. 167, 1238 - 1244.
Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., and Rubinstein, M. (1999) Interleukin-18 binding protein: a novel modulator of the Thl cytokine response. Immunity 10, 127 - 136.
Kim, S.-H., Eisenstein, M., Reznikov, L., et al. (2000) Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA 97, 1190 - 1195.
Xiang, Y. and Moss, B. (2001) Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding protein, J. Virol. 75, 9947 - 9954.
Paulukat, J., Bosmann, M., Nold, M., et al. (2001) Expression and release of IL-18 binding protein in response to IFN-y. J. Immunol. 167, 7038 - 7043.
Mosmann, T. R. and Coffman, R. L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145 - 173.
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., and Glimcher, L. H. (2000) A novel transcription factor, T-bet, directs Thl lineage commitment. Cell 100, 655 - 669.
Mullen, A. C., High, F. A., Hutchins, A. S., et al. (2001) Role of T-bet in commitment of Thl cells before IL-12-dependent selection. Science 298, 1907 - 1910.
Zheng, W.-P. and Flavell, R. A. (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4+ T cells. Cell 89, 587 - 596.
Ouyang, W., Ranganath, S. H., Weindel, K., et al. (1998) Inhibition of Thl developmental mediated by GATA-3 through an IL-4 independent mechanism. Immunity 9, 745 - 755.
Ferber, I. A., Lee, H. J., Zonin, F., et al. (1999) GATA-3 significantly downregulates IFN-y production from developing Thl cells in addition to inducing IL-4 and IL-5 levels. Clin. Immunol. 91, 134-144.
Zhang, D.-H., Yang, L., Cohn, L., et al. (1999) Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3 Immunity 11, 473 - 482.
Agarwal, S. and Rao, A. (1998) Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9, 765 - 775.
Takeda, K., Tsutsui, H., Yoshimoto, T., et al. (1998) Defective NK cell activity and Thl response in IL-18-deficient mice. Immunity 8, 383 - 390.
Ohkusu, K., Yoshimoto, T., Takeda, K., et al. (2000) Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection. Infect. Immun. 68, 2449 - 2456.
Hoshino, T., Yagita, H., Ortldo, R. H., and Young, H. A. (2000) In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur. J. Immunol. 30, 1998 - 2006.
Yoshimoto, T., Mizutani, H., Tsutsui, H., et al. (2000) IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat. Immunol. 1, 132 - 137.
Xu, D., Trajkovic, V., Hunter, D., et al. (2000) IL-18 induces the differentiation of Thl or Th2 cells depending upon cytokine milieu and genetic background. Eur. J. Immunol. 30, 3147 - 3156.
Hoshino, T., Kawase, Y., Okamoto, M., et al. (2001) IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J. Immunol. 166, 7014 - 7018.
Konishi, H., Tsutsui, H., Murakami, T., et al. (2002) IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc. Natl. Acad. Sci. USA 99, 11340 - 11345.
Nakanishi, K., Yoshimoto, T., Kashiwamura, S.-I., Tsutsui, H., and Okamura, H. (2000) Interleukin-18. In: Holland, S. M., ed. Cytokine Therapeutic in Infectious Diseases. Lippincott Williams & Wilkins, Philadelphia, pp. 119 - 144.
Sareneva, T., Julkunen, I., and Matikainen, S. (2000) IFN-a and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 165, 1933 - 1938.
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., and Chisari, F. V. (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825 - 829.
Guidotti, L. G. and Chisari, F. V. (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65 - 91.
Unanue, E. R. (1997) Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158, 11 - 25.
Neighbors, M., Xu, X., Barrat, F., et al. (2001) A critical role for interleukin 18 in primary and memory effector responses to Listeria monocyto genes that extends beyond its effects on interferon y production. J. Exp. Med. 194, 343 - 354.
Edelson, B. T. and Unanue, E. R. (2002) MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169, 3869 - 3875.
Seki, E., Tsutsui, H., Tuji, N. M., et al. (2002) Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocyto genes in mice. J. Immunol. 169, 3863 - 3868.
Swain, S. L. (2001) Interleukin 18: tipping the balance towards a T helper cell 1 response. J. Exp. Med. 194, F11 - F14.
Kawakami, K., Qureshi, M. H., Zhang, T., Okamura, H., Kurimoto, M., and Saito, A. (1997) IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-y production. J. Immunol. 159, 5528 - 5534.
Kawakami, K., Koguchi, Y., Qureshi, M. H., et al. (2000) IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-y production by NK cells. J. Immunol. 165, 941 - 947.
Mattner, F., Magram, J., Ferrante, J., et al. (1996) Genetically resistant mice lacking interleukin12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26, 1553 - 1559.
Wei, X. Q., Leung, B. P., Niedbala, W., et al. (1999) Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163, 2821 - 2828.
Monteforte, G. M., Takeda, K., Rodriguez-Sosa, M., Akira, S., David, J. R., and Satoskar, A. R. (2000) Genetically resistant mice lacking IL-18 gene develop Thl response and control cutaneous Leishmania major infection. J. Immunol. 164, 5890 - 5893.
Singh, R. P., Kashiwamura, S., Rao, P., Okamura, H., Mukherjee, A., and Chauhan, V. S. (2002) The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA. J. Immunol. 168, 4674 - 4681.
Yap, G. S., Ortmann, R., Sheavach, E., and Sher, A. (2001) A heritable defect in IL-12 signaling in B10.Q/J mice. II. Effect on acute resistance to Toxoplasma gondii and rescue by IL-18 treatment. J. Immunol. 166, 5720 - 5725.
Coughlin, C. M., Salhany, K. E., Wysocka, M., et al. (1998) Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441 - 1452.
Chikano, S., Sawada, K., Shimoyama, T., et al. (2000) IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-y-dependent manner. Gut 47, 779 - 786.
Siegmund, B., Lehr, H.-A., Fantuzzi, G., and Dinarello, C. A. (2001) IL-113-converting enzyme (caspase-1) in intestinal inflammation. Proc. Natl. Acad. Sci. USA 96, 13249 - 13254.
Wirtz, S., Becker, C., Blumberg, R., Galle, P. R., and Neurath, M. F. (2002) Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 168, 411 - 420.
Sivakumar, P. V., Westich, G. M., Kanaly, S., et al. (2002) Interleukin 18 is a primary mediator of the inflammation associated with dextran sulfate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812 - 820.
Fujimori, Y., Takatsuka, H., Takemoto, Y., et al. (2000) Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br. J. Haematol. 109, 652 - 657.
Itoi, H., Fujimori, Y., Tsutsui, H., et al. (2001) Fas ligand-induced caspase-l-dependent accumulation of interleukin (IL)-18 in mice with acute graft-versus-host disease. Blood 98, 235 - 237.
Reddy, P., Teshima, T., Kukuruga, M., et al. (2001) Interleukin-18 regulates acute graft-versushost disease by enhancing Fas-mediated donor T cell apoptosis. J. Exp. Med. 194, 1433 - 1440.
Yamanaka, K., Tanaka, M., Tsutsui, H., et al. (2000) Skin-specific caspase-1 transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J. Immunol. 165, 997 - 1003.
Wang, B., Feliciani, C., Howell, B. G., et al. (2002) Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J. Immunol. 168, 3303 - 3308.
McInnes, I. B., Gracie, J. A., and Liew, F. Y. (2001) Interleukin-18: a novel cytokine in inflammatory rheumatic disease. Arthritis Rheum. 44, 1481 - 1483.
Alaaeddine, N., Olee, T., Hashimoto, S., Creighton-Achermann, L., and Lotz, M. (2001) Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum. 44, 1633 - 1643.
Morel, J. C., Park, C. C., Woods, J. M., and Koch, A. E. (2001) A novel role for interleukin-18 in adhesion molecule induction through NFiB and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J. Biol. Chem. 276, 37069 - 37075.
Plater-Zyberk, C., Joosten, L. A., Helsen, M. M., et al. (2001) Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. 108, 18251832.
Park, C. C., Morel, J. C., Amin, A. M., Connors, M. A., Harlow, L. A., and Koch, A. E. (2001) Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167, 1644 - 1653.
Mallat, Z., Corbaz, A., Scoazec, A., et al. (2001) Expression of interleukin-18 in human atherosclerotic plaque and relation to plaque instability. Circulation 104, 1598 - 1603.
Libby, P., Ridker, P. M., and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135 - 1143.
Whitman, S. C., Ravisankar, P., and Daugherty, A. (2002) Interleukin-18 enhances atherosclerosis in apolipoprotin E-'- mice through release of interferon-y. Circ. Res. 90, e34 - e38.
Kosco-Vilbois, M. H. (2002) IL-18-a destabilizer of atherosclerotic disease. Trends Immunol. 23, 123.
Blackenberg, S., Tiret, L., Bickel, C., et al. (2002) Interlelukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106, 24 - 30.
Kiechl, S., Lorenz, E., Reindl, M., et al. (2002) Toll-like receptor 4 polymorphisms and atherosclerosis. N. Engl. J. Med. 347, 185 - 192.
Young, J. L., Sukhova, G. K., Foster, D., Kisiel, W., Libby, P., and Schonbeck, U. (2000) The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin-lp-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J. Exp. Med. 191, 1535 - 1544.
Plant, M., Pierce, J. H., Watson, C. J., Hanley-Hyde, J., Nordan, R. P., and Paul, W. E. (1989) Mast cell lines produce lymphocytes in response to cross-linkage of Fce RI or to calcium ionophores. Nature 339, 64 - 67.
Paul, W. E., Seder, R. A., and Plaut, M. (1993) Lymphokine and cytokine production by Fc RI+ cells. Adv. Immunol. 53, 1 - 29.
Matsuda, H., Watanabe, N., Geba, G. P., et al. (1996) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9, 461 - 466.
Yagi, R., Nagai, H., Iigo, Y., Akimoto, T., Arai, T., and Kubo, M. (2002) Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J. Immunol. 168, 2020 - 2027.
Hoshino, K., Tsutsui, H., Kawai, T., et al. (1999) Generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162, 5041 - 5044.
Hochholzer, P., Lipford, G. B., Wagner, H., Pfeffer, K., and Heeg, K. (2000) Role of interlukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity by normal superantigen reaction in IL-18-deficient mice. Infect. Immun. 68, 3502 - 3508.
Tsutsui, H., Matsui, K., Kawada, N., et al. (1997) IL-18 accounts for both TNF-a-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 159, 3961 - 3967.
Sakao, Y., Takeda, K., Tsutsui, H., et al. (1999) IL-18-deficient mice are resistant to endotoxininduced liver injury but highly susceptible to endotoxin shock. Int. Immunol. 11, 471 - 480.
Kanai, T., Watanabe, M., Oakazawa, A., et al. (2001) Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastrotenterology 121, 875 - 888.
Melnikov, V. Y., Ecder, T., Fantuzzi, G., et al. (2001) Impaired IL-18 processing protects caspase1-deficient mice from ischemic acute renal failure. J. Clin. Invest. 107, 1145 - 1152.
Hedtjarn, M., Leverin, A. L., Eriksson, K., Blomgren, K., Mallard, C., and Hagberg, H. (2002) Interelukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22, 5910 - 5919.
Taneja, V. and David, C. S. (1999) HLA class II transgenic mice as models of human diseases. Immunol. Rev. 169, 67-79.
Gracie, J. A., Forsey, R. J., Chan, W. L., et al. (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 104, 1393 - 1401.
Dayer, J. M. (1999) Interleukin-18, rheumatoid arthritis, and tissue destruction. J. Clin. Invest. 104, 1337-1339.
Wong, C. K., Li, E. K., Ho, C., and Lam, C. W. (2000) Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology 39, 1078 - 1081.
Nicoletti, F., Di Marco, R., Mangano, K., et al. (2000) Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology 24, 342 - 344.
Wei, X., Leung, B. P., Arthur, H. M., McInnes, I. B., and Liew, F. Y. (2001) Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J. Immunol. 166, 517 - 521.
Shi, F.-D., Takeda, K., Akira, S., Sarvetnick, N., and Ljunggren, H.-G. (2000) IL-18 directs auto-reactive T cells and promotes autodestruction in the central nervous system via induction of IFN-y by NK cells. J. Immunol. 165, 3099 - 3104.
Jiang, H.-R., Wei, Z., Niedbala, W., Lumsden, L., Liew, F. Y., and Forrester, J. V. (2001) IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest. Ophthalmol. Vis. Sci. 42, 177-182.
Trinchieri, G. (1989) Biology of natural killer cells. Adv. Immunol. 47, 187 - 376.
Pien, G. C., Satoskar, A. R., Takeda, K., Akira, S., and Biron, C. A. (2000) Selective IL-18 requirements for induction of compartmental IFN-y responses during viral infection. J. Immunol. 165, 4787 - 4791.
Parr, M. B. and Parr, E. L. (1999) The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 258, 282 - 294.
Harandi, A. M., Svennerholm, B., Holmgren, J., and Eriksson, K. (2001) Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virology 75, 6705 - 6709.
Mori, I., Hossain, J., Takeda, K., et al. (2001) Impaired microglial activation in the brain of IL-18gene-disrupted mice after neurovirulent influenza A virus infection. Virology 287, 163 - 170.
Ohteki, T., Fukao, T., Suzue, K., et al. (1999) Interleukin 12-dependent interferon gamma production by CD8a+ lymphoid dendritic cells. J. Exp. Med. 189, 1981 - 1986.
Sugawara, I., Yamada, H., Kaneko, H., Mizuno, S., Takeda, K., and Akira, S. (1999) Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67, 2585 - 2589.
Kinjo, Y., Kawakami, K., Uezu, K., et al. (2002) Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J. Immunol. 169, 323 - 329.
Lauw, F. N., Branger, J., Florquin, S., et al. (2002) IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 168, 372 - 378.
Lim, T. S. and Murphy, J. W. (1980) Transfer of immunity to criptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect. Immun. 30, 5 - 15.
Afonso, L. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G., and Scott, P. (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235 - 237.
Adachi, K., Tsutsui, H., Kashiwamura, S., et al. (2001) Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167, 5928 - 5934.
Finkelman, F. D., Pearce, E. J., Urban, J. F. J., and Sher, A. (1991) Regulation and biological function of helminth-induced cytokine responses. Immunol. Today 12, A62 — A66.
Urban, J. F. Jr., Madden, K. B., Svetíc, A., et al. (1992) The importance of Th2 cytokines in protective immunity to nematodes. Immunol. Rev. 127, 205 - 220.
Locksley, R. M. (1994) Th2 cells: help for helminth. J. Exp. Med. 179, 1405 - 1407.
Helmby, H., Takeda, K., Akira, S., and Grencis, R. K. (2001) Interleukin (IL)-18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J. Exp. Med. 194, 355 - 364.
Helmby, H. and Grencis, R. K. (2002) IL-18 regulates intestinal mastocytosis and Th2 cytokine production independently of IFN-y during Trichinella spiralis infection. J. Immunol. 169, 2553 - 2560.
Csernok, E., Lüdemann, J., Gross, W. L., and Bainton, D. F. (1990) Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am. J. Pathol. 137, 1113 - 1120.
Dolman, K. M., van de Wiel, B. A., Kam, C.-M., et al. (1992) Determination of proteinase 3-ahantitrypsin complexes in inflammatory fluids. FEBS Lett. 2, 117 - 121.
Sugawara, S., Uehara, A., Nochi, T., et al. (2001) Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. 167, 6568 - 6575.
de Saint-Vis, B., Fugier, V. I., Massacrier, C., et al. (1998) The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160, 1666 - 1676.
Stoll, S., Jonuleit, H., Schmitt, E., et al. (1998) Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Thl development. Eur. J. Immunol. 28, 3231 - 3239.
Afkarian, M., Sedy, J. R., Yang, J., et al. (2002) T-bet is a stati-induced regulator for IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3, 549 - 557.
Kojima, H., Takeuchi, M., Ohta, T., et al. (1998) Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem. Biophys. Res. Commun. 244, 183 - 186.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tsutsui, H., Yoshimoto, T., Okamura, H., Akira, S., Nakanishi, K. (2003). IL-18 and IL-18 Receptor Knockout Mice. In: Fantuzzi, G. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-405-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-59259-405-4_18
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-415-9
Online ISBN: 978-1-59259-405-4
eBook Packages: Springer Book Archive